Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 24023068)

1.

HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis.

Miyauchi Y, Sato Y, Kobayashi T, Yoshida S, Mori T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Miyamoto K, Tando T, Morioka H, Matsumoto M, Chambon P, Johnson RS, Kato S, Toyama Y, Miyamoto T.

Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16568-73. doi: 10.1073/pnas.1308755110. Epub 2013 Sep 10.

2.

Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice.

Lee EJ, Kim JL, Kim YH, Kang MK, Gong JH, Kang YH.

Phytomedicine. 2014 Sep 15;21(10):1208-15. doi: 10.1016/j.phymed.2014.04.002. Epub 2014 Jun 2.

PMID:
24932975
3.

Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta.

Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF.

Nat Med. 1996 Oct;2(10):1132-6.

PMID:
8837613
4.

In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.

Most W, Schot L, Ederveen A, van der Wee-Pals L, Papapoulos S, Löwik C.

J Bone Miner Res. 1995 Oct;10(10):1523-30.

PMID:
8686508
5.

Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis.

Pacifici R.

J Bone Miner Res. 1996 Aug;11(8):1043-51. Review.

PMID:
8854239
6.

Fas receptor is required for estrogen deficiency-induced bone loss in mice.

Kovacic N, Grcevic D, Katavic V, Lukic IK, Grubisic V, Mihovilovic K, Cvija H, Croucher PI, Marusic A.

Lab Invest. 2010 Mar;90(3):402-13. doi: 10.1038/labinvest.2009.144. Epub 2010 Jan 18.

7.

Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice.

Onoe Y, Miyaura C, Ito M, Ohta H, Nozawa S, Suda T.

J Bone Miner Res. 2000 Mar;15(3):541-9.

PMID:
10750569
8.

Phospholipase Cγ2 is required for basal but not oestrogen deficiency-induced bone resorption.

Kertész Z, Gyori D, Körmendi S, Fekete T, Kis-Tóth K, Jakus Z, Schett G, Rajnavölgyi E, Dobó-Nagy C, Mócsai A.

Eur J Clin Invest. 2012 Jan;42(1):49-60. doi: 10.1111/j.1365-2362.2011.02556.x. Epub 2011 Jul 12.

9.

Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.

Michael H, Härkönen PL, Väänänen HK, Hentunen TA.

J Bone Miner Res. 2005 Dec;20(12):2224-32. Epub 2005 Aug 1.

PMID:
16294275
10.

Mice lacking the integrin beta5 subunit have accelerated osteoclast maturation and increased activity in the estrogen-deficient state.

Lane NE, Yao W, Nakamura MC, Humphrey MB, Kimmel D, Huang X, Sheppard D, Ross FP, Teitelbaum SL.

J Bone Miner Res. 2005 Jan;20(1):58-66. Epub 2004 Oct 25.

PMID:
15619670
11.

Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow.

Shibata T, Shira-Ishi A, Sato T, Masaki T, Masuda A, Hishiya A, Ishikura N, Higashi S, Uchida Y, Saito MO, Ito M, Ogata E, Watanabe K, Ikeda K.

J Bone Miner Res. 2002 Apr;17(4):622-9.

PMID:
11918219
12.
13.

Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts.

Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, Nakamaru Y, Hiroi E, Hiura K, Kameda A, Yang NN, Hakeda Y, Kumegawa M.

J Exp Med. 1997 Aug 18;186(4):489-95.

14.

Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice.

Kodama I, Niida S, Sanada M, Yoshiko Y, Tsuda M, Maeda N, Ohama K.

J Bone Miner Res. 2004 Feb;19(2):200-6. Epub 2003 Dec 16.

PMID:
14969389
15.

Lipopolysaccharide-mediated enhancement of bone metabolism in estrogen-deficient mice.

Fujita S, Kikuchi T, Sobue T, Suzuki M, Koide M, Noguchi T.

J Periodontol. 2008 Nov;79(11):2173-81. doi: 10.1902/jop.2008.070127 .

PMID:
18980527
16.

Critical role of beta3 integrin in experimental postmenopausal osteoporosis.

Zhao H, Kitaura H, Sands MS, Ross FP, Teitelbaum SL, Novack DV.

J Bone Miner Res. 2005 Dec;20(12):2116-23. Epub 2005 Jul 25.

PMID:
16294265
17.

Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspective.

Zhao R.

Int J Med Sci. 2012;9(9):825-32. doi: 10.7150/ijms.5180. Epub 2012 Oct 27. Review.

18.

Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4.

Knowles HJ, Cleton-Jansen AM, Korsching E, Athanasou NA.

FASEB J. 2010 Dec;24(12):4648-59. doi: 10.1096/fj.10-162230. Epub 2010 Jul 28.

19.

Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.

Iwaniec UT, Yuan D, Power RA, Wronski TJ.

J Bone Miner Res. 2006 Jul;21(7):1068-74.

PMID:
16813527
20.

Persistent bone-sparing effect of interleukin-1 receptor antagonist: a hypothesis on the role of IL-1 in ovariectomy-induced bone loss.

Kimble RB, Kitazawa R, Vannice JL, Pacifici R.

Calcif Tissue Int. 1994 Oct;55(4):260-5.

PMID:
7820776
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk